.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Benztropine mesylate - Generic Drug Details

« Back to Dashboard
Benztropine mesylate is the generic ingredient in two branded drugs marketed by Usl Pharma, Oxford Pharms, Quantum Pharmics, Aspen Global Inc, Oak Pharms Akorn, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Corepharma, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, Merck, and Invagen Pharms, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for benztropine mesylate. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: benztropine mesylate

Tradenames:2
Patents:0
Applicants:17
NDAs:31
Drug Master File Entries: see list5
Suppliers / Packaging: see list34
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: benztropine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL088510-001Jan 31, 1984DISCNNo► subscribe► subscribe
Pliva
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL089059-001Aug 10, 1988RXNo► subscribe► subscribe
Hikma Farmaceutica
BENZTROPINE MESYLATE
benztropine mesylate
INJECTABLE;INJECTION090287-001Aug 31, 2009RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc